enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Reversible cerebral vasoconstriction syndrome - Wikipedia

    en.wikipedia.org/wiki/Reversible_cerebral...

    A 2007 review by Leonard Calabrese and colleagues proposed the name reversible cerebral vasoconstriction syndrome, which has since gained widespread acceptance. [1] [9] This name merges various conditions that were previously treated as distinct entities, including Call-Fleming syndrome, postpartum angiopathy, and drug-induced angiopathy. [6]

  3. Meglitinide - Wikipedia

    en.wikipedia.org/wiki/Meglitinide

    A 2020 Cochrane systematic review did not find enough evidence of reduction of all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to meglitinide for the treatment of type 2 diabetes.

  4. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

  5. What Endocrinologists Want You to Know About Rybelsus and Ozempic

    www.aol.com/endocrinologists-want-know-rybelsus...

    Both drugs help decrease A1Cs (a single blood test that indicates a three-month blood sugar average) in people with type 2 diabetes. Rybelsus. As a type 2 diabetes drug, Rybelsus is a prescription ...

  6. A diabetes drug may help prevent dementia, new research shows

    www.aol.com/diabetes-drug-may-help-prevent...

    SGLT-2 inhibitors are relatively new drugs that treat type 2 diabetes. The first SGLT-2 inhibitor approved for use in the United States was dapagliflozin (Farxiga) , in 2014.

  7. Amy Schumer says she stopped taking Ozempic because of side ...

    www.aol.com/amy-schumer-says-she-stopped...

    Ozempic, a once-weekly injection used for the treatment of type 2 diabetes, has skyrocketed in use after people were reportedly prescribed the diabetes medication as an “off-label” weight loss ...

  8. Insulin glargine/lixisenatide - Wikipedia

    en.wikipedia.org/wiki/Insulin_glargine/lixisenatide

    Insulin glargine/lixisenatide is approved as a prescription for adults with type 2 diabetes mellitus poorly controlled by lixisenatide or basal insulin alone. [6] According to the American Diabetes Association, combination treatment of a GLP-1 receptor agonist with basal insulin should occur after HbA1C levels remain above target (7% for most type 2 people with diabetes) following use of basal ...

  9. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

    www.aol.com/diabetes-drugs-really-safe-reliable...

    GLP-1 drugs for weight loss and type 2 diabetes include dulaglutide, liraglutide, and semaglutide. GIP/GLP-1s. These are dual-acting, meaning they target two receptors in the body: gastric ...